How the Hottest Biotech Sprouted in Iowa
Study Sparks Debate on Accuracy of Genome Tests for Cancer Patients
European Regulators Approved Roche's Avastin for Cervical Cancer Treatment
While a majority of our top fund managers are outperforming this year, three of them truly stand out from the rest given their ability to outperform the market over all time periods.
This fund's comeback from the financial crisis has been balky, but it still has promise.